生合1295.TW Overview
1295
生合
-1.82%
(-0.02)
1295 Overall Performance
1295 AI Analysis & Strategy
Browsing restrictions can be lifted for a fee.
1295 Current Performance
-1.79%
生合
-0.47%
Avg of Sector
-0.01%
TAIEX
1295 Key Information
1295 Profile
Synbio Tech, Inc. operates as a biotechnology company. It engages in the manufacturing of probiotics and related applications. The firm also offers the promotion and sale of lactic acid bacteria (LAB) drinks, human health care LAB powder, and agriculture, forestry, fishery and animal husbandry probiotics in China. The company was founded on June 1, 2000 and is headquartered in Kaohsiung City, Taiwan.
1295 FAQ
When is 1295's latest earnings report released?
The most recent financial report for 生合 (1295) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 1295's short-term business performance and financial health. For the latest updates on 1295's earnings releases, visit this page regularly.
Where does 1295 fall in the P/E River chart?
According to historical valuation range analysis, 生合 (1295)'s current price-to-earnings (P/E) ratio is 21.82, placing it in the Overvalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
How much cash does 1295 have?
At the end of the period, 生合 (1295) held Total Cash and Cash Equivalents of 408.76M, accounting for 0.15 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does 1295 go with three margins increasing?
In the latest report, 生合 (1295) achieved the “three margins increasing” benchmark, with a gross margin of 58.27%%, operating margin of 33.02%%, and net margin of 20.24%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 1295's profit trajectory and future growth potential.
What is the FCF of 1295?
生合 (1295)'s Free Cash Flow (FCF) for the period is 87.02M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 340.49% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.